Antibody response to COVID-19 vaccine in immune-mediated diseases In this cross-sectional study, authors studied hospital workers and a control group to assess antibody response to inactivated COVID-19 vaccine in patients with immune-mediated disease. In the study, 82 hospital workers withRead More
Post-COVID syndrome in non-hospitalized patients In this longitudinal prospective cohort study, authors observed patients over four and seven months after COVID-19 symptom onset to determine symptom presence. The researchers observed 442 and 353 patients over four and seven months, respectively.Read More
Prevalence of post-acute sequelae of SARS-CoV-2 infection In this article authors discuss the persistent symptoms after acute COVID-19 illness and attempt to estimate the prevalence and correlates of post-acute sequelae of SARS-CoV-2 infection (PASC). Research involved a population-based probability surveyRead More
New onset heart failure related to COVID-19 In this article, authors aim to described the point-prevalence and outcomes of new heart failure diagnoses among patients hospitalized with COVID-19. Research was conducted using retrospective analysis of patients whom were admitted withRead More
Acute kidney injury in COVID-19 This article discusses the common and severe renal complications associated with COVID-19 in critically ill patients. Manifestations of acute renal failure may include proteinuria, hematuria, increased serum creatinine, or blood urea nitrogen levels. A meta-analysisRead More
Risk of mortality in patients with COVID-19 with use of NSAID’s In this meta-analysis, authors discuss how the use of NSAID’s have been thought to contribute to adverse outcomes in patients who acquire COVID-19 and aim to review evidence toRead More
Impact of cardiovascular disease on COVID-19 In this systematic review, the association of cardiovascular disease on COVID-19 is discussed. Researchers have found that underlying cardiovascular disease increases risk for infection and speculate that the virus and its receptor, inflammatory factors,Read More
Neurological manifestation of SARS-CoV-2: Inflammation and therapeutics This article discusses extrapulmonary infections and manifestations related to COVID-19. As discussed in previous articles, the usual complaints of ageusia, anosmia, myalgia, and headache are prominent in individuals, however, reports of stroke, encephalopathy,Read More
Long-term complications from COVID-19 As patients have recovered from severe COVID-19, we are beginning to see some of the long term effects related to the infection. Most patients will recover fully after 2 to 6 weeks, but a small percentageRead More
Persistent Post-COVID Syndrome (PPCS) In last week’s post, persistence of COVID symptoms in patients who had recovered from COVID were discussed. In this article, authors refer to persistent post-COVID syndrome or “long COVID” as a pathology in and of itself.Read More